Data / Form D filings / Keliomics, Inc.
Keliomics, Inc.: Form D filings
Keliomics, Inc., a biotechnology company in Portland, OR, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on November 30, 2023, reports $2.3 million sold of a $7 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4640 S. MACADAM AVENUE, SUITE 270, Portland, OR, 97239
- Phone
- (617) 935-2625
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1949231
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 30, 2023 | Amendment | $7,000,000 | $2,275,000 | $4,725,000 | 17 | Sep 26, 2022 | sec.gov |
| Oct 11, 2022 | New notice | $7,000,000 | $250,000 | $6,750,000 | 2 | Sep 26, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frank Lau | Executive Officer, Director | |
| Jason Bourgeois | Executive Officer, Director |
Other biotechnology companies in Oregon that filed recently
- UBIVAC, INC. $80,000 · Aug 27, 2026
- Trace Biosciences Inc. $8.3 million · Aug 12, 2026
Every Form D from the week of Nov 27, 2023 · All recent filings in Oregon · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Keliomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.